President Trump met with pharma CEOs at the White House. After praising investments, a 'most favored nation' drug pricing ...

Charles River Laboratories is set to start a strategic review and add four new board members after it settled on a ...

NewAmsterdam's obicetrapib reduced Lp(a) by 45% in Phase 3; C4 Therapeutics advances cemsidomide while dropping CFT1946; Vivo ...

Theriva Biologics' VCN-01 plus chemotherapy showed improved survival in pancreatic cancer patients vs. chemo alone in Phase ...

Los Angeles-based health system Cedars-Sinai is partnering with venture studio Redesign Health to build health tech startups ...

Novo Nordisk cuts 2025 revenue guidance due to higher than expected impact of US compound pharmacies producing semaglutide.

CRISPR Therapeutics has revealed promising but early data from its first clinical study of a gene editing therapy to lower ...

Attorneys general from 19 states and Washington, DC have filed a lawsuit against the federal government alleging that its ...

Vertex paused an early-stage trial of its inhaled treatment for cystic fibrosis that came from a partnership with Moderna.

NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...

Plus, news about Atara Bio­ther­a­peu­tics, Im­mutep, blue­bird bio, OSE Im­munother­a­peu­tics, Mer­sana Ther­a­peu­tics, ...

The FDA on Tuesday said it is planning on doing more surprise inspections of foreign factories, a day after Trump signed an ...